Psy Therapeutics' Unattributed VC Round

Psy Therapeutics raised a round of funding on October 02, 2019. Investors include Venrock.

Psy Therapeutics develops a pipeline of high potential central nervous system (CNS) therapeutics focused on Anxiety Disorders, Major Depressive Disorder and Dementia. It uses a flexible approach to in…

Articles about Psy Therapeutics' Unattributed VC Round: